Compare Mesoblast Limited (MESO) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Charles Schwab Corporation Common Stock — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Charles Schwab Corporation Common Stock trades at $100.2 (market cap $178.33B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 82.2× Mesoblast Limited's market cap, and Charles Schwab Corporation Common Stock pays a 1.25% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | SCHW | |
|---|---|---|
Market Cap | $2.17B | $178.33B |
Sector | Technology | Financials |
52-Week High | $20.96 | $107.21 |
52-Week Low | $12.88 | $85.35 |
Enterprise Value | $2.17B | — |
Dividend Yield | — | 1.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →
